BioCryst Pharmaceuticals, Inc. (BCRX) CEO Jon Stonehouse on Q2 Results - Earnings Call Transcript

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants John Bluth - SVP, IR and Corporate Communications Jon Stonehouse - CEO Anthony Doyle - CFO Dr. Bill Sheridan - CMO Charlie Gayer - CCO Dr. Helen Thackray - Chief R&D Officer Conference Call Participants Stacy Ku - Cowen and Company Jon Wolleben - JMP Securities Chris Raymond - Piper Sandler Jessica Fye - JPMorgan Maury Raycroft - Jefferies Gena Wang - Barclays Brian Abrahams - RBC Cap ...